Progressive Relaxation Exercise Applied to Palliative Caregivers on Coping With Stress,Anxiety

Sponsor
Istanbul Sabahattin Zaim University (Other)
Overall Status
Completed
CT.gov ID
NCT04880941
Collaborator
(none)
60
1
2
2
29.9

Study Details

Study Description

Brief Summary

It is important to consider the needs of palliative care caregivers and to plan interventions for psychosocial problems.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Progressive Relaxation Exercise
N/A

Detailed Description

Cognitive-behavioral methods, which may be applied as relaxation aids in controlling the anxiety levels.

Study Design

Study Type:
Interventional
Actual Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
This study is an experimental study with pre-test and post-test control groups.This study is an experimental study with pre-test and post-test control groups.
Masking:
Single (Participant)
Masking Description:
Progressive Relaxation Exercise and control group
Primary Purpose:
Supportive Care
Official Title:
The Effect of Progressive Relaxation Exercise Applied to Palliative Caregivers on Coping With Stress and Anxiety Variables
Actual Study Start Date :
Apr 30, 2021
Actual Primary Completion Date :
Jun 10, 2021
Actual Study Completion Date :
Jun 30, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Progressive Relaxation Exercise

The Progressive Relaxation Exercise will be held 7 days for 4 weeks, a total of twenty eight sessions. Each session is set as fifty minutes

Behavioral: Progressive Relaxation Exercise
In the progressive relaxation technique, the tension and anxiety in skeletal muscles are relatively relieved.
Other Names:
  • Control group
  • No Intervention: Control group

    Routine maintenance will be applied

    Outcome Measures

    Primary Outcome Measures

    1. Coping With Stress in Palliative Caregivers [1 week]

      Stress Coping Styles Scale-The minimum score to be obtained from the scale is 30, and the maximum score is 120. The high scores indicate that the person copes effectively with stress.

    2. Coping With Stress in Palliative Caregivers [4 week]

      Stress Coping Styles Scale-The minimum score to be obtained from the scale is 30, and the maximum score is 120. The high scores indicate that the person copes effectively with stress.

    Secondary Outcome Measures

    1. Anxiety in Palliative Caregivers [1 week]

      The State-Trait Anxiety Inventory (STAI) is a commonly used measure of trait and state anxiety (Spielberger, Gorsuch, Lushene, Vagg, & Jacobs, 1983). It can be used in clinical settings to diagnose anxiety. It also is often used in research as an indicator of caregiver distress. Form Y, its most popular version, has 20 items for assessing trait anxiety and 20 for state anxiety. State anxiety items include: "I am tense; I am worried" and "I feel calm; I feel secure." Trait anxiety items include: "I worry too much over something that really doesn't matter" and "I am content; I am a steady person." All items are rated on a 4-point scale (e.g., from "Almost Never" to "Almost Always"). Higher scores indicate greater anxiety.

    2. Anxiety in Palliative Caregivers [4 week]

      The State-Trait Anxiety Inventory (STAI) is a commonly used measure of trait and state anxiety (Spielberger, Gorsuch, Lushene, Vagg, & Jacobs, 1983). It can be used in clinical settings to diagnose anxiety. It also is often used in research as an indicator of caregiver distress. Form Y, its most popular version, has 20 items for assessing trait anxiety and 20 for state anxiety. State anxiety items include: "I am tense; I am worried" and "I feel calm; I feel secure." Trait anxiety items include: "I worry too much over something that really doesn't matter" and "I am content; I am a steady person." All items are rated on a 4-point scale (e.g., from "Almost Never" to "Almost Always"). Higher scores indicate greater anxiety.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 65 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • To be able to communicate adequately

    • Not having psychiatric problems

    • Volunteering to participate in research

    • Caregivers whose patients will be in bed for at least 4 weeks

    Exclusion Criteria:
    • None

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Istanbul Sabahattin Zain Universitiy Istanbul State Turkey 34303

    Sponsors and Collaborators

    • Istanbul Sabahattin Zaim University

    Investigators

    • Study Chair: Zülfünaz ÖZER, PhD, Istanbul Sabahattin Zaim University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Zülfünaz ÖZER, PhD., Assistant Prof, Istanbul Sabahattin Zaim University
    ClinicalTrials.gov Identifier:
    NCT04880941
    Other Study ID Numbers:
    • 2021/02
    First Posted:
    May 11, 2021
    Last Update Posted:
    Jul 22, 2021
    Last Verified:
    Jul 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Zülfünaz ÖZER, PhD., Assistant Prof, Istanbul Sabahattin Zaim University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jul 22, 2021